This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, M. V.
Right arrow Articles by Walboomers, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, M. V.
Right arrow Articles by Walboomers, J. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Apr 1995, 901-905, Vol 33, No. 4
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes

MV Jacobs, AM de Roda Husman, AJ van den Brule, PJ Snijders, CJ Meijer and JM Walboomers
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.

In recent years, general primer-mediated PCR assays have been developed to detect a broad spectrum of human papillomavirus (HPV) genotypes. In this study, a procedure enabling a simple group-specific differentiation of high-risk (HPV-16, -18, -31, -33, -35, -39, -45, - 51, -52, -54, -56, and -58) and low risk (HPV-6, -11, -34, -40, -42, - 43, and 44) HPVs following an HPV general primer-mediated (GP5+/GP6+) PCR is presented. By computer-assisted sequence analysis, oligonucleotides (30-mers) specific for 19 different HPV genotypes were selected from the internal part of the 150-bp GP5+/GP6(+)-amplified region. These oligo probes were tested for specificity in a Southern blot analysis of PCR products derived from the same panel of HPV types. No cross-hybridizations were found. The sensitivities of the oligo probes varied from the femtogram level for the well-amplified HPV types like HPV-16 and -18 to the picogram level for the less-well amplified HPV types like HPV-39 and -51. These sensitivities were reached when the oligo probes were applied both individually and in a cocktail. On the basis of these results, two cocktail oligo probes that enabled a specific and sensitive differentiation between low- and high-risk HPV types were composed.


This article has been cited by other articles:

  • Vaccarella, S., Herrero, R., Snijders, P. J F, Dai, M., Thomas, J. O, Hieu, N. T., Ferreccio, C., Matos, E., Posso, H., de Sanjose, S., Shin, H. R., Sukvirach, S., Lazcano-Ponce, E., Munoz, N., Meijer, C. J L M, Franceschi, S., the IARC HPV Prevalence Surveys (IHPS) Study Group, (2008). Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 37: 536-546 [Abstract] [Full Text]  
  • Vaccarella, S., Herrero, R., Dai, M., Snijders, P. J.F., Meijer, C. J.L.M., Thomas, J. O., Hoang Anh, P. T., Ferreccio, C., Matos, E., Posso, H., de Sanjose, S., Shin, H.-R., Sukvirach, S., Lazcano-Ponce, E., Ronco, G., Rajkumar, R., Qiao, Y.-L., Munoz, N., Franceschi, S., and IARC HPV Prevalence Surveys Study Group, (2006). Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys.. Cancer Epidemiol. Biomarkers Prev. 15: 2148-2153 [Abstract] [Full Text]  
  • Han, J., Swan, D. C., Smith, S. J., Lum, S. H., Sefers, S. E., Unger, E. R., Tang, Y.-W. (2006). Simultaneous Amplification and Identification of 25 Human Papillomavirus Types with Templex Technology. J. Clin. Microbiol. 44: 4157-4162 [Abstract] [Full Text]  
  • Jiang, H.-L., Zhu, H.-H., Zhou, L.-F., Chen, F., Chen, Z. (2006). Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system. J Med Microbiol 55: 715-720 [Abstract] [Full Text]  
  • Vaccarella, S., Franceschi, S., Herrero, R., Munoz, N., Snijders, P. J.F., Clifford, G. M., Smith, J. S., Lazcano-Ponce, E., Sukvirach, S., Shin, H.-R., de Sanjose, S., Molano, M., Matos, E., Ferreccio, C., Thi Hoang Anh, P., Thomas, J. O., Meijer, C. J.L.M., IARC HPV Prevalence Surveys Study Group, (2006). Sexual Behavior, Condom Use, and Human Papillomavirus: Pooled Analysis of the IARC Human Papillomavirus Prevalence Surveys.. Cancer Epidemiol. Biomarkers Prev. 15: 326-333 [Abstract] [Full Text]  
  • Bodaghi, S., Yamanegi, K., Xiao, S.-Y., Da Costa, M., Palefsky, J. M., Zheng, Z.-M. (2005). Colorectal Papillomavirus Infection in Patients with Colorectal Cancer. Clin. Cancer Res. 11: 2862-2867 [Abstract] [Full Text]  
  • Youshya, S, Purdie, K, Breuer, J, Proby, C, Sheaf, M T, Oliver, R T D, Baithun, S (2005). Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J. Clin. Pathol. 58: 207-210 [Abstract] [Full Text]  
  • Smith, K. L., Tristram, A., Gallagher, K. M., Fiander, A. N., Man, S. (2005). Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. Int Immunol 17: 167-176 [Abstract] [Full Text]  
  • Ferreccio, C., Prado, R. B., Luzoro, A. V., Ampuero, S. Ll., Snijders, P. J.F., Meijer, C. J.L.M., Vaccarella, S. V., Jara, A. T., Puschel, K. I., Robles, S. C., Herrero, R., Franceschi, S. F., Ojeda, J. M. (2004). Population-Based Prevalence and Age Distribution of Human Papillomavirus Among Women in Santiago, Chile. Cancer Epidemiol. Biomarkers Prev. 13: 2271-2276 [Abstract] [Full Text]  
  • Sotlar, K., Diemer, D., Dethleffs, A., Hack, Y., Stubner, A., Vollmer, N., Menton, S., Menton, M., Dietz, K., Wallwiener, D., Kandolf, R., Bultmann, B. (2004). Detection and Typing of Human Papillomavirus by E6 Nested Multiplex PCR. J. Clin. Microbiol. 42: 3176-3184 [Abstract] [Full Text]  
  • Oh, T. J., Kim, C. J., Woo, S. K., Kim, T. S., Jeong, D. J., Kim, M. S., Lee, S., Cho, H. S., An, S. (2004). Development and Clinical Evaluation of a Highly Sensitive DNA Microarray for Detection and Genotyping of Human Papillomaviruses. J. Clin. Microbiol. 42: 3272-3280 [Abstract] [Full Text]  
  • Klaassen, C. H. W., Prinsen, C. F. M., de Valk, H. A., Horrevorts, A. M., Jeunink, M. A. F., Thunnissen, F. B. J. M. (2004). DNA Microarray Format for Detection and Subtyping of Human Papillomavirus. J. Clin. Microbiol. 42: 2152-2160 [Abstract] [Full Text]  
  • Iftner, T., Villa, L. L. (2003). Chapter 12: Human Papillomavirus Technologies. J Natl Cancer Inst Monogr 2003: 80-88 [Abstract] [Full Text]  
  • Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., Snijders, P. J.F., Meijer, C. J.L.M., the International Agency for Research on Cancer Mu, (2003). Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. NEJM 348: 518-527 [Abstract] [Full Text]  
  • Smith, J. S., Herrero, R., Bosetti, C., Munoz, N., Bosch, F. X., Eluf-Neto, J., Castellsague, X., Meijer, C. J. L. M., Van den Brule, A. J. C., Franceschi, S., Ashley, R. (2002). Herpes Simplex Virus-2 as a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer. JNCI J Natl Cancer Inst 94: 1604-1613 [Abstract] [Full Text]  
  • Roda, A., Mirasoli, M., Venturoli, S., Cricca, M., Bonvicini, F., Baraldini, M., Pasini, P., Zerbini, M., Musiani, M. (2002). Microtiter Format for Simultaneous Multianalyte Detection and Development of a PCR-Chemiluminescent Enzyme Immunoassay for Typing Human Papillomavirus DNAs. Clin. Chem. 48: 1654-1660 [Abstract] [Full Text]  
  • Castellsague, X., Bosch, F. X., Munoz, N., Meijer, C. J.L.M., Shah, K. V., de Sanjose, S., Eluf-Neto, J., Ngelangel, C. A., Chichareon, S., Smith, J. S., Herrero, R., Moreno, V., Franceschi, S., the International Agency for Research on Cancer Mu, (2002). Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners. NEJM 346: 1105-1112 [Abstract] [Full Text]  
  • van den Brule, A. J. C., Pol, R., Fransen-Daalmeijer, N., Schouls, L. M., Meijer, C. J. L. M., Snijders, P. J. F. (2002). GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes. J. Clin. Microbiol. 40: 779-787 [Abstract] [Full Text]  
  • Coutlee, F., Gravitt, P., Kornegay, J., Hankins, C., Richardson, H., Lapointe, N., Voyer, H., Franco, E. (2002). Use of PGMY Primers in L1 Consensus PCR Improves Detection of Human Papillomavirus DNA in Genital Samples. J. Clin. Microbiol. 40: 902-907 [Abstract] [Full Text]  
  • Erles, K., Rohde, V., Thaele, M., Roth, S., Edler, L., Schlehofer, J. R. (2001). DNA of adeno-associated virus (AAV) in testicular tissue and in abnormal semen samples. Hum Reprod 16: 2333-2337 [Abstract] [Full Text]  
  • Klug, S. J., Wilmotte, R., Santos, C., Almonte, M., Herrero, R., Guerrero, I., Caceres, E., Peixoto-Guimaraes, D., Lenoir, G., Hainaut, P., Walboomers, J. M. M., Munoz, N. (2001). TP53 Polymorphism, HPV Infection, and Risk of Cervical Cancer. Cancer Epidemiol. Biomarkers Prev. 10: 1009-1012 [Abstract] [Full Text]  
  • Herrington, C S, Worsham, M, Southern, S A, Mackowiak, P, Wolman, S R (2001). Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix. Mol. Pathol. 54: 160-164 [Abstract] [Full Text]  
  • Rozendaal, L, Westerga, J, van der Linden, J C, Walboomers, J M M, Voorhorst, F J, Risse, E K J, Boon, M E, Meijer, C J L M (2000). PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J. Clin. Pathol. 53: 606-611 [Abstract] [Full Text]  
  • van Duin, M., Snijders, P. J. F., Vossen, M. T. M., Klaassen, E., Voorhorst, F., Verheijen, R. H. M., Helmerhorst, T. J., Meijer, C. J. L. M., Walboomers, J. M. M. (2000). Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J. Gen. Virol. 81: 317-325 [Abstract] [Full Text]  
  • Kleter, B., van Doorn, L.-J., Schrauwen, L., Molijn, A., Sastrowijoto, S., ter Schegget, J., Lindeman, J., ter Harmsel, B., Burger, M., Quint, W. (1999). Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus. J. Clin. Microbiol. 37: 2508-2517 [Abstract] [Full Text]  
  • de Gruijl, T., Bontkes, H., Walboomers, J., Coursaget, P, Stukart, M., Dupuy, C, Kueter, E, Verheijen, R., Helmerhorst, T., Duggan-Keen, M., Stern, P., Meijer, C., Scheper, R. (1999). Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. J. Gen. Virol. 80: 399-408 [Abstract]